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Abstract-l. Several hypotheses have been advanced to explain the activating function of streptokinase. 
The predominant hypothesis uggests astable equimolar streptokinase-plasmin(ogen) complex, activating 
free plasminogen by an active centre, which is located in the plasmin(ogen) part of the complex. 
2. This hypothesis cannot explain a number of phenomena nd certain accumulated experimental data, 
for example: rabbit and bovine plasminogen activation by streptokinase, not forming stable complexes 
with these plasminogens; possible activation with pH 4 2, in the presence of urea, during modification of 
streptokinase tyrosine residues, i.e. when these two proteins cannot form a stable complex. 
3. On the basis of acquired experimental data the following concept is suggested: the activating function 
of streptokinase is oxygen-dependent and is realised with the help of superoxide radical due to the 
Oi-generating ability of plasminogen and the Ot-converting ability of streptokinase. 
INTRODUCTION 
The plasminogen activation mechanism draws, at 
present, increasing attention due to the major role of 
fibtinolysis in realisation of numerous physiological 
and pathological processes for example: thrombo- 
genesis and thrombolysis; tissue growth and differ- 
entiation; malignant and metastatic spreading of 
tumors; and embryo implantation. 
We can distinguish two pathways of plasminogen 
(Pg) conversion into active serine proteinase i.e. 
plasmin: “proteinase” and “non-proteinase” (Jack- 
son et al., 1980). In the first pathway urokinase and 
tissue Pg activators, being serine proteinases with 
high specificity, directly act on the Pg molecule. The 
second pathway is realised by the addition to Pg of 
some specific proteins, devoid of proteinase and any 
hydrolase activity: streptokinase (SK), staphylo- 
kinase, and some other factors. 
The clarification of the “non-proteinase” pattern is 
still evidently important for a full understanding of 
the fibrinolysis regulation pathway, in view of the 
possible existence of other Pg activation initiators 
beside SK and staphylokinase. 
Proceeding from the above, it is imperative to 
decode SK activating function, as SK is one of the 
most effective activators of Pg, synthesized by a 
number of ,Y-hemolytic streptococci strains of A, C 
and G serologic groups. 
Different hypotheses have been advanced to explain 
SK activating function. The most well-known are: the 
hypothesis of direct SK action on Pg (Summaria et 
al., 1969; Kline and Ts’ao, 1971); the hypothesis of 
SK interaction with specific protein-proactivator, 
leading to active Pg activator formation (Ablondi and 
Hagan, 1958; Takada et al., 1970); the hypothesis of 
SK-Pg stoichiometric activating complex (Reddy and 
Markus, 1972; Brockway and Castellino, 1974; 
Castellino, 1979; Reddy, 1988). 
At present, the activating complex hypothesis 
remains predominant and serves as a scientific expla- 
nation of SK action mechanism. The failure, as yet, 
to discover any enzymatic activity in SK, and its 
ability to activate very pure Pg samples, in which all 
impurities are excluded, cause this state of affairs. 
This hypothesis is confirmed by the fact, that 
numerous researches using physical methods proved 
the formation of stable SK-Pg stoichiometric com- 
plex (De Renzo et al., 1963; Davies et al., 1964; Buck 
and Boggiano, 1971; Summaria and Robbins, 1971). 
Besides, it has been established, that addition of this 
complex to bovine, sheep or pig Pgs (poorly activated 
by SK), causes quick tranformation of zymogens into 
active plasmin (Castellino, 1979). Also it is already 
known, that inhibitor treatment (for example, with 
di-isopropyl fluorophosphate) of Pg part active centre 
disturbs the activating function of this complex (Buck 
et al., 1968). 
As a necessary pre-condition of Pg activation by 
SK, this hypothesis advances a stage of stable com- 
plex formation between these proteins, the complex 
itself being the activator of free Pg molecules. 
CONTRADICTIONS WITH THE HYPOTHESIS OF 
ACTIVATING “STREPTOKINAS&PLASMIN(OGEN)” 
COMPLEX 
A lot of experimental data have recently been 
produced, that contradict, and cannot be explained 
by this hypothesis. For example, rabbit Pg is known 
to be effectively activated by SK (Schick and 
Castellino, 1973). There is some evidence of bovine 
Pg slow activation, although the complex of the 
proteins has not been found (Miillertz and Lassen, 
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Table 1. Effect of urea on streptokinase activity (n-5; fibrin plate lysis method; Nikandrov el al., 1986a) 
Urea Streptokinsse activity Urea Streptokinase. activity 
concentration concentration 
(M) Id ILJjmg protein % WM) IO3 IU/mg protein % 
0 120* 10 100 5 12056 100 
: 102k6 91+ 4 8S 1 6 8 125+_3 6  7 104 5
3 102i6 85 
1953). Using the method of lysis of fibrin plates, 
containing human plasminogen, specifically adsorbed 
on fibrin fibers, we have found out, that SK is able 
to activate Pg in the presence of 8 M urea (Table 1) 
and with pH < 2 (Fig. 1; Nikandrov et al., 1986a). At 
the same time, in these conditions SK-Pg stable 
complex is not formed (De Renzo et al., 1963; Davies 
et al., 1964, Summaria and Robbins, 1971). We also 
found, that after some of the tyrosine residue is 
iodinated, the SK molecule looses its ability (accord- 
ing to gel-chromatography) to form stable complexes 
with human Pg, but its ability to activate this 
zymogen is only weakly affected (Nikandrov and 
Kazyuchits, 1989). 
Finally, it is worth pointing out, that the activator- 
complex hypothesis advances the active centre of 
Pg as a main functional mechanism within the com- 
plex (Buck et al., 1968; Buck and Boggiano, 1971). 
Obviously, in this case, the activation mechanism 
should correspond to the serine proteinase catalytic 
i;l’, / / / , tf 
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Fig. 1. Effect of solution pH on the activating function of 
streptokinase; fibrin plate lysis method {Nikandrov er al., 
1986a). 
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Fig. 2. Effect of singlet oxygen, ‘OH or O;-radicals scav- 
engers on the activating function of streptokinase (sodium 
azi& l ---@, L-histidine o-0, L-tryptophan A-A, 
n-mannitol A-& ni~otetr~o~~ blue m-a, 
adrenaline x-x ); fibrin plate lysis method (Nikandrov 
et al., 1987c). 
mechanism, a major stage of which is acyl-enzyme 
formation with the establishment of a covalent bond. 
Nevertheless, all attempts to discover SK-Pg.Pg 
ternary complex failed. Only recently (S~rna~a 
et al., 1987) has SK-plasmin light chain.Pg complex 
formation been described. But the last phenomenon 
does not correspond to the pattern which should have 
emerged if the case of “serine type” catalysis is to be 
realised: it must be possible to produce a ternary 
complex, in which the Pg molecule is not reduced. 
All the above phenomena enabled us to assume, 
that SK-Pg stable complex formation is not necess- 
ary for zymogen activation, and that mechanism of 
this activation may be somewhat different, compared 
with serine proteinase action. 
PREMISKS OF THK NEW CONCEPT OF 
STRRPTOKINASE-DEPENDENT PLASMINOGEN 
ACTIVATION 
On the basis of accumulated experimental data 
we could suggest another SK-activating functional 
mechanism. These data are as follows: 
(1) Pg activation by SK (not by urokinase, nor 
tissue Pg activator) is sharply inhibited by superoxide 
radical scavengers with 0.01 M concentration (Nikan- 
drov et al., 1987~). ‘OH-radical scavengers (man~to~, 
formate) or singlet oxygen scavengers (sodium azide, 
histidine, tryptophan) have no inhibiting effect 
(Fig. 2). 
(2) Human Pg activation can be produced in the 
absence of SK by treating zymogen with H20Z 
(2 0.5 M) (Fig. 3), or with superoxide radical gener- 
ation systems (Nikandrov et al., 1986d, Nikandrov 
and Pyzhova, 1989). This activation is less effective 
than that with SK. Besides, Pg activation by HzO, is 
inhibited by superoxide radical scavengers (nitroblue 
tetrazolium, for example), but is not affected by 
‘OH-radical or singlet oxygen scavengers (Table 2; 
Nikandrov and Pyzhova, 1989). 
Recently, oxidative inactivation of a number of 
proteinase inhibitors has been described, including 
that of a%-antiplasmin and tissue Pg activator inhibi- 
tor (Stief and Heimburger, 1988; Stief et al., 1988; 
Lawrence and Loskutoff, 1986). This phenomenon 
demonstrates the theoretical possibility of increased 
proteolytic activity of Pg samples (if they contain 
trace impurities of tissue Pg activator) by inactivating 
the named inhibitors. However, an important feature 
of proteinase inhibitors oxidative inactivation is its 
inhibition and, consequently, Pg activation inhibition 
by singlet oxygen scavengers: odium azide and meth- 
ionine (Stief and Heimburger, 1988). At the same 
time, the described phenomenon of Pg activation in 
the presence of active forms of oxygen is similarIy 
unaffected by these scavengers, like the Pg activation 
process. 
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Table 2. Effect of scavengers of active oxygen species on the human 
plasminogen activation by H,O, (n-5; fibrin plate lysis method; 
Nikandrov and Pyzhova, 1989) 
Experimental condition 
Plasminogen 
Plasminogen + streptokinase, 750 IU 
Plasminogen + H,O,, 5.6 M 
Plasminogen + mannitol, 
0.01 M + H,O,, 5.6 M 
Plasminogen + sodium azide, 
0.01 M + H,O,, 5.6 M 
Plasminogen + L-tryptophane, 
0.01 M + H,O,, 5.6 M 
Plasminogen + nitrotetrazolium blue, 
0.01 M + H,O,. 5.6 M 
Fibrinolysis zones 
(mm’) 
0 
468f20 
250 + I5 
240?15 
309 * 23 
282 f 15 
0 
i 
P SK 400 
“E 
: t 
E 320 
C / 
4 , .-.- I 
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lg CHeOZ3 
Fig. 3. Effect of H,O, addition to human plasminogen 
samples on their fibrinolytic activity (C-control, without 
Hz02; SK-plasminogen samples with addition of streptok- 
inase, 75OIU); fibrin plate lysis method (Nikandrov and 
Pyzhova, 1989). 
(3) Pg is able to generate oxygen radicals during 
Hz02 decomposition (Fig. 4; Nikandrov et al., 
1986c), or spontaneously, it seems, during slow auto- 
oxidation (Fig. 5). Concentration of radicals is weak, 
and the adrenaline oxidation rate constant with 
adrenochrom formation in presence of Pg equals 
5. 10m5 min-’ (Nikandrov and Pyzhova, 1988b). 
Human and rabbit Pgs (well-activated by SK) 
demonstrate the above ability, in contrast to bovine 
Pg which is more poorly activated by SK. 
2.4 r 
0 2 4 6 
Minutes 
Fig. 4. Chemiluminescence kinetics in “luminol-H,O,” sys- 
tem under additions of human (l), rabbit (2) or bovine (3) 
plasminogens. Protein concentration in reaction mixture is 
54 pg/ml (Nikandrov et al., 1986c). 
(4) 0; generation by Pg is 60% increased with 
EDTA and effectively inhibited by o-phenantroline 
(Table 3; Nikandrov and Pyzhova, 1988b). 
Phenantroline and sodium diethyldithiocarbamate 
enhance native SK activating function by 20-25%, 
while EDTA reduces it by 25% (Table 4). After 
Minutes 
4 12 20 26 
Minutes 
Fig. 5. Adrenochrom formation kinetics under the presence of human plasminogen (a) and semilogarith- 
mic anamorphose of this kinetics (b). Final concentration of adrenaline-O.01 M; plasminogen in the 
reaction mixture is 2.6 mg, pH 7.0, 25”C, air atmosphere (Nikandrov and Pyzhova, 1988b). 
SC 241-D 
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Table 3. Effect of some active oxygen species scavengers and 
chelating agents on the adrenaline oxidation by human plasminogen 
(n-5; Nikandrov and Pyzhova, 1988b) 
Experimental Adrenochrome formation 
conditions (x IO-‘M.min-‘) 
Control (plasminogen) 
+ r_-histidine, 0.02 M 
+NaN,, 0.01 M 
+ Ethanol, 1 M 
+o-mannitol, 0.01 M 
+Catalase, 2. IO-‘M 
+ Superoxide dismutase, 
+KCN, 0.001 M 
+EDTA, 0.01 M 
+ o -Phenantroline. 0.0 1 M 
15.0+ 1.4 
13.5 + 1.5 
12.8 * 1.2 
15.0 +_ 0.9 
14.4 + 0.9 
16.4 + 1.0 
8.0 + 0.9’ 
15.8 f 1.2 
24.0 i 1.7* 
7.1 f 0.4* 
l P < 0.05. 
pre-treatment of SK with 80% DMSO, o-phenen- 
throline and diethyldithiocarbamate decrease the ac- 
tivating function by 15-30%, and EDTA halves it 
(Nikandrov et al., 1987~). These facts enable us to 
assume, that the above Pg and SK functions are 
preconditioned by the presence of transition metals in 
these proteins (Nikandrov and Pyzhova, 1988a). 
(5) In model systems of superoxide radical gener- 
ation SK is able to inhibit nitroblue tetrazolium 
reduction (Nikandrov et al., 1986b). This phenom- 
enon is very important for medical care, as new 
approaches for the use of SK preparations arise. SK 
itself neither decomposes H,Oz, nor forms oxygen 
radicals (Nikandrov et al., 1986~). 
The above experimental data suggest an oxygen- 
dependent Pg activation pathway, not linked with 
serine proteinase function (Nikandrov and Pyzhova, 
1988a). 
According to this suggestion, Pg activation is re- 
alised due to zymogen’s ability of slow 0; generation 
(as an initial stage), and to SK’s ability to react with 
both this radical and Pg, resulting in zymogen acti- 
vation. 
THE NEW INTERPRETATION OF STREPTOKINASE 
ACTIVATING FUNCTION RAISES NEW PROBLEMS 
It is obvious, that superoxide radical exclusion 
from the Pg-SK system completely halts the process. 
Table 4. Effect of chelating agents on the activating function of 
streptokinase before and after treatment by 80% (v/v) dimethylsul- 
foxide (n-5: fibrin alate lvsis method: Nikandrov ef al.. 1986b1 
Experimental conditions 
Streptokinase in 0.06 M phosphate 
buffer, pH 7.4 (control) 
+EDTA, 0.01 M 
+ Sodium diethyldithiwarbamate, 
0.01 M 
+8-Hydroxyquinoline, 0.01 M 
+o-Phenanthroline, 0.01 M 
Streptokinase in 80% dimethylsulfoxide 
(control) 
+EDTA, 0.01 M 
+Sodium diethyldithiocarbamate, 0.01 M 
+ 8-Hydroxyquinoline, 0.01 M 
fo-Phenanthroline, 0.01 M 
l P c 0.05. 
Fibrinolysis zones 
(mm? 
465 f 6.5 
349 + 9.8’ 
581 f 15.6’ 
507 f 27.2 
558k 14.1* 
437 * 14.1 
265 + 20.0. 
391 * 10.0’ 
326 + 13’ 
391 f 20’ 
But it is worth pointing out, that even weak concen- 
tration of this radical is sufficient for effective acti- 
vation. A sharp increase in its concentration not 
only enhances the activation process, but even 
slows it down due to unspecific damaging of protein 
molecules. More than that, high 0; concentration 
increases its transformation into ‘OH-radical and 
singlet oxygen. 
It is only logical to conclude, that, if absolute 0; 
concentration is not involved, then during Pg acti- 
vation by SK catalytic mechanism must be realised, 
which hampers the dissipation of radicals and ensures 
their specific action on certain Pg molecule sites. All 
the above presupposes realisation of the catalytic 
mechanism by SK. 
The following questions arise: how is the activation 
process realised and what is the SK catalysis mechan- 
ism? It seems, that the initial stage is a SK-superoxide 
radical reaction. Besides, affinity between SK and 05 
is very high, because radical scavengers inhibit the 
process in relatively high concentration. SK much 
more effectively activates Pg, when water is substi- 
tuted with organic solvents: aliphatic alcohols and 
such aproton solvents as dioxane, dimethylsulfoxide, 
and dimethylformamide (Fig. 6; Nikandrov et al., 
1987a). These conditions favourably influence free 
‘OH-radical-fixation and increase 0; life-time. 
Fig. 6. Streptokinase-initiated fibrinolysis under the partial substitution of water for proton developing 
(methanol O-0, ethanol x-x , I-propanol a-0) and aproton (acetone A-A, 1 +dioxane A--& 
dimethylsulfoxide q-_O, N,N-dimethyl-formamide a-m) solvents; fibrin plate lysis method (Nikan- 
drov et al., 1987a). 
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Further detailed research is needed on the Pg 
activation mechanism, if possible at the electron level. 
At present, taking into account the above, we can 
presume the following concept. It is probable, that 
SK is able to transfer an electron from O$ to certain 
sites on the Pg molecule, namely, on the carbonyl 
carbon atom of the peptide bond Arg,,-Val,,, (the 
reason may be specific structure of Pg). As a result, 
the peptide bond may become destabilized and bro- 
ken. Naturally, in case this mechanism exists, one 
should assume the possibility of both intramolecular 
transfer of the electron into Pg (from the Ot 
generation site) and intermolecular one. It ensures 
realisation of slow Pg autoactivation process. 
The mechanism of peptide bond destabilization, 
through electron transfer on the carbonyl carbon 
atom, is described based on experiments with excited 
tryptophan molecules (Kayushin et al., 1976). The 
report on activation process of ribonucleotide- 
reductase from E. coli should also be remembered 
(Eliasson et al., 1986). This enzyme possibly functions 
only after tyrosine radical formation in the active 
centre of the enzyme. Such a radical is formed in the 
presence of superoxide radical and superoxide dis- 
mutase (Eliasson et al., 1986). In the absence of 
superoxide dismutase active ribonucleotide-reductase 
does not appear. The mechanism of this process is 
still unclear. In this case we can compare ribonucleo- 
tide-reductase activation with Pg activation by SK: in 
both cases the active enzyme form is produced in the 
presence of superoxide radical and superoxide dis- 
mutase. That is why, we hope, that all the above 
mentioned assumptions have some real foundation. 
CONCLUSION 
Stemming from the above, the suggested concept 
for SK activating function is based on oxygen(super- 
oxide)-dependent Pg activation. To discover this 
activation mechanism we need to carry out a compre- 
hensive study of the submolecular and electron pro- 
cesses in the Pg-SK system. Our suggestions raise, at 
least, four important questions: 
(1) Is SK a catalyst? According to publications, SK 
differs from other catalyst-proteins in one respect: SK 
splits during activation (Markus et al., 1976). But we 
must take into account that SK action on Pg results 
in plasmin-active proteinase. For human and animal 
organisms SK is a xenogenic protein, whose evol- 
utionary purpose (unlike enterokinase, which is often 
used as an analogy when considering SK activating 
function-Wohl et al., 1978) does not, most probably, 
include activation of animal proteinase zymogens. 
Apart from this phenomenon, there is no evidence to 
consider SK as devoid of a catalytic function. 
(2) Much more important is the question of SK 
catalytic function mechanism, considering its ability 
to react with superoxide radical. The discovery of this 
mechanism demands extensive studies on the sub- 
molecular and electron levels in the Pg-SK complex. 
In this respect, it seems important to study Pg and SK 
active centers, conducting “operations” with super- 
oxide radicals: state of metals, their coordination by 
ligands, etc. 
This issue has a clear practical importance in the 
treatment, with SK preparations, of pathological 
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Fig. 7. Effect of ATP (@-a), ADP (O-O), S-AMP 
(A--A), GTP (A-A) additions on the streptokinase- 
initiated fibrinolysis (Nikandrov et al., 1987b). 
processes unrelated to hemostatic system disturb- 
ances. 
(3) It is extremely important to reveal SK’s physio- 
logical role in streptococcus. This aspect is completely 
enigmatic. We can only point out, that SK is found 
in hemolytic streptococcus membranes (cellular 
membranes), while active SK is absent in cellular 
cytoplasm (Nikandrov et al., 1990). Besides, SK 
activating function is inhibited by ATP and 3’S’- 
AMP (Figs 7 and 8; Nikandrov et al., 1987b). With 
regard to proteolytic processes, all these facts are 
unusual. As all the described nucleotide effects on 
proteolytic enzyme activity were realised in proteol- 
ysis activation and, as a rule, depended on the 
number of phosphate residues in the nucleotide mol- 
ecule (Pillai et al., 1983; Watabe and Kimura, 1985); 
i.e. they could be explained by the presence of 
energy-rich bonds; and do not manifest themselves 
with 3’,5’-AMP action, it is possible to presume that 
SK has some connection with the streptococcus cell- 
energy process. The discovery of a mechanism of 
reaction between SK and superoxide radical will help 
to specify these concepts more precisely. 
(4) Finally, the last task is to determine the fre- 
quency of endogenous oxygen radicals participating 
in zymogen activation of other proteinases and in the 
-4 -3 -2 -1 
Ig M 
Fig. 8. Changes of activating function of streptokinase after 
addition of 3’,5’-AMP (m-0) or 2’,3’-AMP (0-O) 
(Nikandrov ef al., 1987b). 
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catalytic action of proteolytic enzymes. This problem 
is more significant than SK action and its solution 
will seriously influence proteolysis theory. During 
proteolytic action of pepsin and papain we found 
an analogous inhibiting effect of superoxide radical 
scavenger (nitroblue tetrazolium) (Nikandrov, 1988). 
The catalytic mechanism of serine proteinases is 
especially interesting and is explained by a number 
of hypotheses, but every one of them has its limi- 
tations. 
As a whole, the found phenomenon in the first 
case of endogenously formed superoxide radical 
participation in limited proteolysis process mechan- 
ism. 
SUMMARY 
The mechanism of Pg activating function of SK 
is now most often explained from the standpoint 
of an activator-complex hypothesis. This complex 
is a stable equimolar complex between SK and 
plasmin(ogen). According to this hypothesis, a stage 
of the above complex-formation is a necessary con- 
dition for Pg activation by SK, and the very process 
is realised with the help of an active centre of serine 
proteinase type, which functions in the plasmin(ogen) 
part of the complex. 
However, this hypothesis cannot explain the very 
slow activation of bovine Pg and activation of rabbit 
Pg, which do not form stable complexes with SK. 
Adsorbed on fibrin fibers human Pg is possibly 
activated in the presence of 8 M urea or with 
pH < 2.0; i.e. in the conditions preventing stable 
activator-complex formation. Besides, SK activating 
function does not disappear after partial iodination 
of its tyrosine residues, which makes impossible the 
formation of stable complex with human Pg. 
A new hypothesis of SK activating function is 
suggested on the basis of following data. Pg acti- 
vation by SK is inhibited by superoxide radical 
scavengers. Human Pg can be partially activated 
during its treatment with superoxide radical gener- 
ating systems or H,O, (20.5 M). In the last case, 
activation is completely inhibited by the addition 
of nitroblue tetrazolium, but not by sodium azide, 
nor other singlet oxygen or OH-radical scavengers. 
Human or rabbit Pg is able to generate active oxygen 
species during H,O, decomposition, or superoxide 
radical during slow auto-oxidation. Bovine Pg mani- 
fests this ability very weakly. It is presumed that 
SK has a catalytic function, hampering superoxide 
radical dissipation and transferring electrons from 
these radicals to certain site of the Pg molecule. This 
process can cause formation of carbonyl carbon 
radical of the bond Arg,,-Val,,, and destabilize this 
bond. A concept of an oxygen-dependent pathway of 
Pg activation is suggested. From the point of view of 
this hypothesis the following problems are out- 
lined; mechanism of SK catalytic function on electron 
level (along with disclosing metal-containing site 
topography); its physiological function in the strepto- 
coccus cell (taking into account inhibition of acti- 
vating function by ATP and 3’,5’-AMP); the place 
of endogenous active oxygen species in activation 
of other zymogens and in proteinase catalytic 
function. 
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